about
Autoimmune liver serology: current diagnostic and clinical challengesAntibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitisThe role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritisCrohn's disease specific pancreatic antibodies: clinical and pathophysiological challengesInfections as a cause of autoimmune rheumatic diseasesDisease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosisPrimary biliary cirrhosis and the nuclear pore complex.Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data.Polarisation of major histocompatibility complex II host genotype with pathogenesis of European Brown Hare syndrome virus.Fetomaternal alloimmunity as a cause of liver disease.Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosisAutoimmunity and environment: am I at risk?Virus, liver and autoimmunity.Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.Bioinformatic and immunological analysis reveals lack of support for measles virus related mimicry in Crohn's disease.Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature.Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.Glycoprotein 2 antibodies in Crohn's disease.E. coli Induced Experimental Model of Primary Biliary Cirrhosis: At Last.Vitamin D in autoimmune liver disease.Primary biliary cirrhosis: family storiesHelicobacter pylori and autoimmune disease: cause or bystander.Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA.Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.Immunopathogenesis of primary biliary cirrhosis: an old wives' tale.Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma.Epstein-barr virus as a trigger of autoimmune liver diseases.Sex differences associated with primary biliary cirrhosis.Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXRIleal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease.TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis.Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment.New platform technology for comprehensive serological diagnostics of autoimmune diseasesA study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics.TRAF1-C5 affects quality of life in patients with primary biliary cirrhosisThe Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease.Factors Affecting Exercise Test Performance in Patients After Liver Transplantation.Bacteria and primary biliary cirrhosis.Primary biliary cirrhosis-specific antimitochondrial antibodies in neonatal haemochromatosis.
P50
Q24644140-D55D367A-5761-4BE5-A091-009AA1BCD5D6Q24798067-73B37A6F-E688-42AF-8494-39266E06EC13Q26821943-5D959978-F792-468A-B19B-A67107564AA2Q26823779-859ACF03-D1B7-4E33-9C49-9654CBB3BEF8Q28074204-D2C1F06A-9BC1-4BFC-A841-89E95F59B5E3Q28259544-5D645E5C-3CD1-4EDC-B89B-6D048B2AECB3Q30415170-47350A9C-352A-4331-9674-5D0672844E9BQ31133026-5225E3C2-5412-49B2-803B-D0E942E4DA94Q31140159-6E94E703-09BC-40A3-B1F8-747C142A1904Q33423039-4FE2DC38-E219-485A-AFA4-88BB498FFDFAQ33634999-668F97AB-2DAA-41AE-B286-637CD3EC203BQ33825348-C4F0C31B-F0C7-4D25-BA13-EAE007617DFBQ34059192-F8326C29-99AF-4FD9-A3FC-0B9BBA42CA64Q34199391-0FE2EED6-635C-430F-A474-58B871C287C8Q34227147-5C37DE4E-9252-4CCE-8B3E-9165CE8D6339Q34346124-1D51A0D8-988B-43AE-90F5-6BE7F352C59AQ34367414-BD85C5F5-ACAF-4C63-8CBF-5E6B1060426BQ34750329-C35EB5B8-3ED6-4405-865F-276780680596Q34793579-135ADF82-D732-4FE8-90CE-730A4D80423FQ34813106-6766E21C-3183-4D4C-920C-60F34E6E762FQ35038800-305F68B1-A6B8-407E-B2AE-D55A3FDF0611Q35103687-EE6FC07D-5F6C-4F48-8D0D-9FB2BFD3DF84Q35309080-CA7A0525-86DE-47F5-9D43-9960C0F70E31Q35523768-22DD68B0-F987-4D7C-8E9F-16F308108F96Q35609106-40AFCA15-D82D-4F43-8C16-50A764136682Q35614763-3FB30934-39DF-4467-9B15-73745BFDB1A5Q35864817-74B58C7B-39DE-4709-95BB-67D2427CEE09Q36010920-1B77A1B6-BDF8-4C9C-86C5-33349BC4BF9CQ36014535-F76596EF-7B8B-4EC5-BE4D-ECE65E1F02ADQ36173223-777D73DF-6A8F-4515-9D69-AD3CE632A798Q36355419-932BF03A-4AAD-4D24-A059-DE1541085AD7Q36361121-1FBE9543-853A-4893-8E9D-E1544499F195Q36361343-010F9305-B899-4327-B949-151D735EA649Q36505735-FDFBF7F0-BC9C-4642-BDFB-5AE59D2A167AQ36509963-120AE109-DEB7-4AA1-A69F-AB673EAAC80DQ36848255-27C1F038-80E4-48D7-9F1E-F0B1032BD6ADQ36898669-3EC62A07-66AE-4940-B9DB-CE56F2F91DE5Q36923179-1ABB6A6E-0998-48A3-B04D-1EF0C3C75704Q37170862-89D980EF-7684-47C5-827C-A1A924CD119FQ37220305-F1AF608A-D3B4-428B-9617-63D739A74DB6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dimitrios P Bogdanos
@nl
Dimitrios P Bogdanos
@sl
Dimitrios P. Bogdanos
@en
Dimitrios P. Bogdanos
@es
type
label
Dimitrios P Bogdanos
@nl
Dimitrios P Bogdanos
@sl
Dimitrios P. Bogdanos
@en
Dimitrios P. Bogdanos
@es
prefLabel
Dimitrios P Bogdanos
@nl
Dimitrios P Bogdanos
@sl
Dimitrios P. Bogdanos
@en
Dimitrios P. Bogdanos
@es
P106
P1153
6603843484
P21
P2798
P31
P496
0000-0002-9697-7902